Prostate Cancer Trials

The Prostate Cancer Clinical Trials Consortium (PCCTC) is a premier clinical research organization specializing in the design and execution of multicenter clinical trials for prostate cancer. Founded in 2005 through a collaboration between the Prostate Cancer Foundation and Memorial Sloan Kettering Cancer Center, the PCCTC operates as a network of leading academic institutions. It provides a streamlined infrastructure for drug development, offering services such as protocol development, site selection, and data management. The consortium also maintains the ProstateCancerTrials.org platform, a comprehensive clinical trial finder for patients and clinicians. By facilitating high-impact research, the PCCTC aims to accelerate the transition of promising therapeutic candidates from the laboratory to the clinic to improve outcomes for patients with prostate cancer.